Tariff Expansion Threat:
Donald Trump signaled upcoming tariffs on pharmaceuticals and semiconductors, two sectors heavily represented in the NASDAQ 100. These measures could:
Raise consumer costs.
Disrupt tech and healthcare supply chains.
Add margin pressure on multinational firms.
Corporate Impact:
Rio Tinto revealed $300M in losses from US aluminum tariffs on Canadian output.
Canada-US trade talks will intensify, but tariffs appear likely to remain, adding to cost overhang for manufacturers and downstream users.
Fed Leadership Uncertainty:
Kevin Hassett is emerging as the frontrunner to replace Fed Chair Jerome Powell in 2026.
Trump is critical of Powell, even citing Fed building renovation costs as a potential fireable offense.
This adds uncertainty to monetary policy continuity, especially as inflation rises and rate path expectations diverge.
401(k) and Private Equity Access:
The administration is finalizing an executive order allowing 401(k) plans to invest in private equity, a move that could:
Increase alternative asset exposure.
Boost private market valuations.
Signal a policy tilt toward financial market liberalization, which may help sustain risk sentiment in the medium term.
Conclusion for NASDAQ 100 (NSDQ100) Trading
The near-term risk for NASDAQ 100 is tilted negative due to the tariff threats on semiconductors and pharma, both major index components.
Fed leadership uncertainty could inject volatility into rate expectations, pressuring tech valuations sensitive to discount rate changes.
However, the longer-term policy shift toward broader 401(k) access to private markets could support overall market sentiment and capital flows.
Bias: Cautiously Bearish in the short term due to trade and Fed risks; neutral to slightly bullish medium term if private capital access reforms proceed and trade escalation is contained.
Key Support and Resistance Levels
Resistance Level 1: 23080
Resistance Level 2: 23170
Resistance Level 3: 23250
Support Level 1: 22750
Support Level 2: 22670
Support Level 3: 22590
This communication is for informational purposes only and should not be viewed as any form of recommendation as to a particular course of action or as investment advice. It is not intended as an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Opinions, estimates and assumptions expressed herein are made as of the date of this communication and are subject to change without notice. This communication has been prepared based upon information, including market prices, data and other information, believed to be reliable; however, Trade Nation does not warrant its completeness or accuracy. All market prices and market data contained in or attached to this communication are indicative and subject to change without notice.
Donald Trump signaled upcoming tariffs on pharmaceuticals and semiconductors, two sectors heavily represented in the NASDAQ 100. These measures could:
Raise consumer costs.
Disrupt tech and healthcare supply chains.
Add margin pressure on multinational firms.
Corporate Impact:
Rio Tinto revealed $300M in losses from US aluminum tariffs on Canadian output.
Canada-US trade talks will intensify, but tariffs appear likely to remain, adding to cost overhang for manufacturers and downstream users.
Fed Leadership Uncertainty:
Kevin Hassett is emerging as the frontrunner to replace Fed Chair Jerome Powell in 2026.
Trump is critical of Powell, even citing Fed building renovation costs as a potential fireable offense.
This adds uncertainty to monetary policy continuity, especially as inflation rises and rate path expectations diverge.
401(k) and Private Equity Access:
The administration is finalizing an executive order allowing 401(k) plans to invest in private equity, a move that could:
Increase alternative asset exposure.
Boost private market valuations.
Signal a policy tilt toward financial market liberalization, which may help sustain risk sentiment in the medium term.
Conclusion for NASDAQ 100 (NSDQ100) Trading
The near-term risk for NASDAQ 100 is tilted negative due to the tariff threats on semiconductors and pharma, both major index components.
Fed leadership uncertainty could inject volatility into rate expectations, pressuring tech valuations sensitive to discount rate changes.
However, the longer-term policy shift toward broader 401(k) access to private markets could support overall market sentiment and capital flows.
Bias: Cautiously Bearish in the short term due to trade and Fed risks; neutral to slightly bullish medium term if private capital access reforms proceed and trade escalation is contained.
Key Support and Resistance Levels
Resistance Level 1: 23080
Resistance Level 2: 23170
Resistance Level 3: 23250
Support Level 1: 22750
Support Level 2: 22670
Support Level 3: 22590
This communication is for informational purposes only and should not be viewed as any form of recommendation as to a particular course of action or as investment advice. It is not intended as an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Opinions, estimates and assumptions expressed herein are made as of the date of this communication and are subject to change without notice. This communication has been prepared based upon information, including market prices, data and other information, believed to be reliable; however, Trade Nation does not warrant its completeness or accuracy. All market prices and market data contained in or attached to this communication are indicative and subject to change without notice.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.